ATE121293T1 - Verwendung eines stoffes, dessen hauptbestandteil ein triglyzerid ist, als wirkstoff mit biologischer wirkung auf die darmmucosa sowie zubereitung die diesen wirkstoff enthält. - Google Patents

Verwendung eines stoffes, dessen hauptbestandteil ein triglyzerid ist, als wirkstoff mit biologischer wirkung auf die darmmucosa sowie zubereitung die diesen wirkstoff enthält.

Info

Publication number
ATE121293T1
ATE121293T1 AT91901713T AT91901713T ATE121293T1 AT E121293 T1 ATE121293 T1 AT E121293T1 AT 91901713 T AT91901713 T AT 91901713T AT 91901713 T AT91901713 T AT 91901713T AT E121293 T1 ATE121293 T1 AT E121293T1
Authority
AT
Austria
Prior art keywords
active ingredient
biological effect
intestinal mucosa
triglyceride
substance
Prior art date
Application number
AT91901713T
Other languages
English (en)
Inventor
Sven Froekjaer
Tomas Tage Hansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8148900&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE121293(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE121293T1 publication Critical patent/ATE121293T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT91901713T 1989-12-22 1990-12-21 Verwendung eines stoffes, dessen hauptbestandteil ein triglyzerid ist, als wirkstoff mit biologischer wirkung auf die darmmucosa sowie zubereitung die diesen wirkstoff enthält. ATE121293T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK657689A DK657689D0 (da) 1989-12-22 1989-12-22 Middel med biologisk virkning paa tarmslimhinden

Publications (1)

Publication Number Publication Date
ATE121293T1 true ATE121293T1 (de) 1995-05-15

Family

ID=8148900

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91901713T ATE121293T1 (de) 1989-12-22 1990-12-21 Verwendung eines stoffes, dessen hauptbestandteil ein triglyzerid ist, als wirkstoff mit biologischer wirkung auf die darmmucosa sowie zubereitung die diesen wirkstoff enthält.

Country Status (8)

Country Link
EP (1) EP0509009B1 (de)
JP (1) JPH05502669A (de)
AT (1) ATE121293T1 (de)
AU (1) AU638541B2 (de)
CA (1) CA2072010A1 (de)
DE (1) DE69018836T2 (de)
DK (2) DK657689D0 (de)
WO (1) WO1991009597A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU626197B2 (en) * 1989-04-07 1992-07-23 New England Deaconess Hospital Corporation Short-chain triglycerides
AU645070B2 (en) * 1990-04-10 1994-01-06 Nb International Technologies Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients DO NOT SEAL - SEE LETTER DATED 22.03.94
SE9002732D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product containing growth factor
JPH08509513A (ja) * 1993-04-23 1996-10-08 ロダース・クロックラーン・ビー・ブイ 消化性の改良された滋養油脂
PT748196E (pt) * 1994-03-01 2000-11-30 Procter & Gamble Penso higienico com triseccoes
EP0739589B1 (de) * 1995-04-28 2001-06-13 Loders Croklaan B.V. An polyungesättigten Fettsäuren reiche Triglyceride
US6410078B1 (en) 1995-04-28 2002-06-25 Loders-Croklaan B.V. Triglycerides, rich in polyunsaturated fatty acids
AU6869996A (en) * 1995-09-13 1997-04-01 Morten Sloth Weidner Use of esters of polyhydric alcohols to enhance the oral bioavailability of drug substances as well as novel esters and pharmaceutical compositions containing them
MX2021005670A (es) * 2018-12-17 2021-06-08 Nestle Sa Butirato alimenticio.
US20220079908A1 (en) 2018-12-21 2022-03-17 Societe Des Produits Nestle S.A. Dietary butyrate for treating or preventing an allergic disorder
BR112021020020A2 (pt) * 2019-05-21 2021-12-07 Nestle Sa Butirato dietário
JP2022533927A (ja) * 2019-05-21 2022-07-27 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 食品用ブチレート及びその使用
EP4068988A1 (de) * 2019-12-05 2022-10-12 Société des Produits Nestlé S.A. Diätetisches butyrat und dessen verwendungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE407180C (de) * 1920-04-25 1924-12-09 Wilhelm Normann Dr Verfahren zur Herstellung von gemischten Glyceriden
US2879281A (en) * 1955-06-29 1959-03-24 Eastman Kodak Co Trans esterification of triglycerides by means of plural metal catalyst
DE2905979C2 (de) * 1979-02-16 1981-01-22 Carl-Jacob Gatzen Verwendung von acetylierten, destillierten Monoglyceriden zur Behandlung von Fettstoffwechselstörungen beim Menschen
US4701469A (en) * 1983-04-15 1987-10-20 Roussel Uclaf Triglycerides, process for therapeutical applications and compositions containing them
JPS6387988A (ja) * 1986-10-01 1988-04-19 Nisshin Oil Mills Ltd:The 消化吸収性の良い油脂
FR2617161B1 (fr) * 1987-06-29 1989-10-27 Azar Robert Nouveaux glycerides d'acide gras insature et leur procede d'obtention

Also Published As

Publication number Publication date
JPH05502669A (ja) 1993-05-13
WO1991009597A1 (en) 1991-07-11
AU638541B2 (en) 1993-07-01
DK0509009T3 (da) 1995-08-07
CA2072010A1 (en) 1991-06-23
AU7046691A (en) 1991-07-24
EP0509009B1 (de) 1995-04-19
DE69018836T2 (de) 1995-11-16
DK657689D0 (da) 1989-12-22
DE69018836D1 (de) 1995-05-24
EP0509009A1 (de) 1992-10-21

Similar Documents

Publication Publication Date Title
ATE121293T1 (de) Verwendung eines stoffes, dessen hauptbestandteil ein triglyzerid ist, als wirkstoff mit biologischer wirkung auf die darmmucosa sowie zubereitung die diesen wirkstoff enthält.
ES2036737T3 (es) Procedimiento para la obtencion de mezclas farmaceuticas.
NL300224I1 (nl) 3-Benzazepinzonen gesubstitueerd met een benzocyclobutyl-of indanylalkyla-minoalkylgroep, bruikbaar voor de behandeling van cardiovasculaire aandoeningen.
BR9100435A (pt) Composto,composicao farmaceutica,uso,metodo de tratamento de um animal,processos para a preparacao da um composto e de uma composicao farmaceutica
ES2167377T3 (es) Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos.
ES2054842T3 (es) Analogo del factor viii, procedimiento de preparacion y composicion farmaceutica que lo contiene.
ES2146339T3 (es) Procedimiento no invasivo para la obtencion de un material a traves de la piel.
ES2168395T3 (es) Nueva formulacion antitrombotica, procedimiento para su preparacion y utilizacion de la misma.
ES2193246T3 (es) Cefalosporinas antibacterianas.
ES2133285T3 (es) Polipeptidos hidrosolubles que tienen una alta afinidad para los interferones alfa y beta.
ES2063767T3 (es) Esteres aromaticos policiclicos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
ZA90966B (en) Oxidized diphenylheteroalkanes,the preparation and use thereof
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
ZA886097B (en) Pharmaceutical composition for the treatment of psoriasis
DE69104083D1 (de) Neue Antiulcus-Substanz.
ES2087279T3 (es) El uso de giberelinas para el tratamiento de la prostatitis y la psoriasis.
ES2037278T3 (es) Tratamiento de la esterilidad.
ES499363A0 (es) Procedimiento para la obtencion de derivados de fenilpipera-cina de 1,3,4-oxadiazolilfenoles
DE69124380D1 (de) Verfahren und zusammensetzungen für die behandlung durch t-zellen vermittelter krankheiten
AT399504B (de) Neue aminopropoxyimino-cycloalkanderivate, deren herstellung, arzneimittel, die diese verbindungen als wirkstoff enthalten sowie verfahren zur herstellung derselben
ATE4988T1 (de) Antibiotika, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
FR2644459B1 (fr) Esters retinoiques de l-cladinose, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
ES2060440T3 (es) Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos.
ES2063765T3 (es) Esteres cicloalifaticos insaturados de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.